{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibo3f3lntrqp6ewzetyoaeumsalnbubcxfmirwontz3idr3peypli",
    "uri": "at://did:plc:ox2kiwcr2xmn32p25g472pp7/app.bsky.feed.post/3mmaezohlird2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreie3mkaz2k7fy2n4vihxk7xhap7rwdelqebm35wdweksnmgnxvi5um"
    },
    "mimeType": "image/webp",
    "size": 51616
  },
  "path": "/releases/2026/05/260518041432.htm",
  "publishedAt": "2026-05-19T09:05:57.000Z",
  "site": "https://www.sciencedaily.com",
  "textContent": "People who lost significant weight while taking Ozempic, Wegovy, Mounjaro, or Saxenda had sharply lower risks of major obesity-related health problems, including sleep apnea and kidney disease. Those who gained weight instead faced higher risks — especially for heart failure — even though many patients discontinued the medications within a year.",
  "title": "People who lost the most weight on Ozempic saw huge health benefits"
}